Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer-Reference-Cited by-同舟云学术

Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer

Published:2020-05-13 Issue:4 Volume:6 Page:283-296
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Pathol Clin Res

Author:

Roseweir Antonia K¹²^ORCID,Park James H¹^ORCID,Hoorn Sanne ten³,Powell Arfon GMT⁴,Aherne Susan⁵,Roxburgh Campbell SD¹²,McMillan Donald C¹,Horgan Paul G¹,Ryan Elizabeth⁵,Sheahan Kieran⁵,Vermeulen Louis³,Paul James⁶,Harkin Andrea⁶,Graham Janet⁶,Sansom Owen²^ORCID,Church David N⁷⁸^ORCID,Tomlinson Ian⁹,Saunders Mark¹⁰,Iveson Tim J¹¹,Edwards Joanne²^ORCID

Affiliation:

1. School of Medicine University of Glasgow Glasgow UK

2. Institute of Cancer Sciences University of Glasgow Glasgow UK

3. Laboratory for Experimental Oncology and Radiobiology, Center for Experimental Molecular Medicine, Amsterdam UMC University of Amsterdam, Cancer Center Amsterdam, Oncode Institute Amsterdam The Netherlands

4. Division of Cancer and Genetics Cardiff University Cardiff UK

5. School of Medicine University College Dublin and Centre for Colorectal Disease, St Vincent's University Hospital Dublin Ireland

6. CRUK Clinical Trials Unit The Beatson West of Scotland Cancer Centre, Gartnavel Hospital Glasgow UK

7. Wellcome Centre for Human Genetics University of Oxford Oxford UK

8. NIHR Oxford Biomedical Research Centre Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital Oxford UK

9. Edinburgh Cancer Research Centre, IGMM University of Edinburgh Edinburgh UK

10. The Christie NHS Foundation Trust Manchester UK

11. Southampton University Hospital NHS Foundation Trust Southampton UK

Funder

Cancer Research UK

Royal College of Physicians and Surgeons of Glasgow

University of Glasgow